Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603351'
s Days Payable Range Over the Past 10 Years
Min: 40.17 Med: 51.68 Max: 89.43
Current: 41.74
During the past 12 years, Nanjing Well Pharmaceutical Group Co's highest Days Payable was 89.43. The lowest was 40.17. And the median was 51.68.
SHSE:603351's Days Payable is ranked worse than 82.16% of 925
companies
in the Drug Manufacturers industry
Industry Median: 89.27
vs SHSE:603351: 41.74
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanjing Well Pharmaceutical Group Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Nanjing Well Pharmaceutical Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanjing Well Pharmaceutical Group Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nanjing Well Pharmaceutical Group Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Nanjing Well Pharmaceutical Group Co's Days Payable falls into.
Nanjing Well Pharmaceutical Group Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanjing Well Pharmaceutical Group Co (SHSE:603351) has a Days Payable of 37.73 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nanjing Well Pharmaceutical Group Co and its competitors. This is 27% below median its historical median of 51.68. Over the past decade, Nanjing Well Pharmaceutical Group Co's Days Payable has ranged from 40.17 to 89.43. According to the industry distribution chart, Nanjing Well Pharmaceutical Group Co ranks #760 out of 925 companies in the Drug Manufacturers industry, placing it in the top 82.2%.
Is Nanjing Well Pharmaceutical Group Co's Days Payable too high?
Nanjing Well Pharmaceutical Group Co's current Days Payable of 37.73 is 27% below median its 10-year median of 51.68. Over the past 10 years, this metric has ranged from a low of 40.17 to a high of 89.43. The Drug Manufacturers industry median Days Payable is 89.27. Nanjing Well Pharmaceutical Group Co's value of 37.73 is 57.7% below this industry median. Based on the distribution chart, Nanjing Well Pharmaceutical Group Co ranks #760 out of 925 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Nanjing Well Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Well Pharmaceutical Group Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Nanjing Well Pharmaceutical Group Co ranks #760 out of 925 companies for Days Payable. This places Nanjing Well Pharmaceutical Group Co in the lower half of its industry. The industry median Days Payable is 89.27. Nanjing Well Pharmaceutical Group Co's value of 37.73 is 57.7% below this benchmark. Historically, Nanjing Well Pharmaceutical Group Co's own Days Payable has ranged from 40.17 to 89.43 over the past decade. While the company's 10-year median is 51.68 vs. the industry median of 89.27, Nanjing Well Pharmaceutical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 89.27, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanjing Well Pharmaceutical Group Co's current Days Payable of 37.73 is 57.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nanjing Well Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 89.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanjing Well Pharmaceutical Group Co's current Days Payable is 37.73, which is 27% below median its own 10-year median of 51.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Well Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Well Pharmaceutical Group Co (SHSE:603351) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.01, compared to a current price of ¥26.93 — trading 3.9% below its estimated fair value. The current Days Payable is 37.73, which is 27% below median its 10-year median of 51.68 and 57.7% below the Drug Manufacturers industry median of 89.27. Nanjing Well Pharmaceutical Group Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Nanjing Well Pharmaceutical Group Co (SHSE:603351), the current Days Payable is 37.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanjing Well Pharmaceutical Group Co (SHSE:603351) Overvalued in 2026?
Based on GuruFocus' analysis, Nanjing Well Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥26.93 is trading 3.9% below its estimated GF Value™ of ¥28.01.
GuruFocus considers Nanjing Well Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for SHSE:603351:
Days Payable: 37.73 (27% below median its 10-year median of 51.68)
GF Value™: ¥28.01 vs. price of ¥26.93 (3.9% below fair value)
Industry Position: 57.7% below the Drug Manufacturers median (#760 of 925)
No single metric tells the full story. See the SHSE:603351 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanjing Well Pharmaceutical Group Co Ltd is engaged in research and development, production and sales of pharmaceutical auxiliary materials and synthetic lubricating base oil and other products. The company uses a variety of pharmaceutical dosage forms such as injection, oral administration and external use to guarantee the molding, effectiveness, stability and safety of pharmaceutical dosage forms.
81GF Score
Get the complete analysis for SHSE:603351
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603351 has been successfully added to your 
